← SynDRA
BUFLOMEDIL
SynDRA canonical compound SYN0005785 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | ADRA1A |
| Mechanism of action | Adrenergic receptor antagonist |
| Indication | peripheral artery disease (PAD) |
| Disease area | cardiology |
All known targets
- ADRA1A
- ADRA1B
- ADRA1D
- ADRA2A
- ADRA2C
- CACNA1C
- CACNG1
- EBP
- ERG2
- SIGMAR1
Mechanisms of action (all sources)
- Calcium channel blocker
- Adrenergic receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- OPRK1
- KCNH2
- ACHE
- MAOA
- NPY1R
- MMP9
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- LMNA
- NR1I2
- LCK
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH3
- HRH2
- HRH1
- NPY2R
- NR3C1
- ADORA1
- OPRD1
- TTR
- THRB
- TDP1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLC6A4
- SLC6A3
- SLC6A2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Cardiovascular Agents
- Vasodilator Agents
ATC classes
- C04A · PERIPHERAL VASODILATORS
Cross-references
Synonyms
- buflomedil hydrochloride
- buflomedil HCl
- Loftyl
- Buflomedil hydrochloride
- Buflomedilum
- 4-(1-Pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone
- V7I71DQ432
- 4-(pyrrolidin-1-yl)-1-(2,4,6-trimethoxyphenyl)butan-1-one
- blufomedil
- bufomedil
- RefChem:121854
- DTXCID902697
- C04AX20
- 2,4,6-trimethoxyphenyl-3-pyrrolidine propyl ketone
- 1-Butanone, 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-
- 4-pyrrolidin-1-yl-1-(2,4,6-trimethoxyphenyl)butan-1-one
- 2',4',6'-Trimethoxy-4-(1-pyrrolidinyl)butyrophenone
- Buflomedil (INN)
- BUFLOMEDIL [INN]
- Buflomedilum [INN-Latin]
- Buflomedil [INN:BAN:DCF]
- NCGC00016831-01
- EINECS 259-851-3
- CAS-35543-24-9
- UNII-V7I71DQ432
- BUFLOMEDIL [MI]
- Prestwick0_000426
- Prestwick1_000426
- Prestwick2_000426
- Prestwick3_000426
- BUFLOMEDIL [WHO-DD]
- BSPBio_000412
- SCHEMBL150905
- SPBio_002351
- BPBio1_000454
- orb1710724
- CHEBI:94538
- HY-B0484A
Look up BUFLOMEDIL in the interactive SynDRA portal →